These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23828263)

  • 21. [Cytosine deaminase and thymidine kinase double suicide gene system driven by carcinoembryonic antigen promoter for the treatment of colorectal carcinoma xenograft in nude mice].
    Huang ZJ; Feng QZ; You J; Xu L; Luo WY; Yi WC; Zeng YY; Luo Q
    Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(28):2235-40. PubMed ID: 24169337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of different methods to assess the cytotoxic effects of cytosine deaminase and thymidine kinase gene therapy.
    Corban-Wilhelm H; Ehemann V; Becker G; Greulich D; Braun K; Debus J
    Cancer Gene Ther; 2004 Mar; 11(3):208-14. PubMed ID: 14671673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene.
    Kim JH; Kolozsvary A; Rogulski K; Khil MS; Brown SL; Freytag SO
    Cancer J Sci Am; 1998; 4(6):364-9. PubMed ID: 9853135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Suicide gene therapy for glioma using HSV-tk/GCV system].
    Xu L; Ge K; Zheng Z
    Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):353-7. PubMed ID: 10920915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The targeted gene (KDRP-CD/TK) therapy of breast cancer mediated by SonoVue and ultrasound irradiation in vitro.
    Li XH; Zhou P; Wang LH; Tian SM; Qian Y; Chen LR; Zhang P
    Ultrasonics; 2012 Jan; 52(1):186-91. PubMed ID: 21906771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene therapy with HSV1-sr39TK/GCV exhibits a stronger therapeutic efficacy than HSV1-TK/GCV in rat C6 glioma cells.
    Li LQ; Shen F; Xu XY; Zhang H; Yang XF; Liu WG
    ScientificWorldJournal; 2013; 2013():951343. PubMed ID: 23533367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A preliminary study on the construction of double suicide gene delivery vectors by mesenchymal stem cells and the in vitro inhibitory effects on SKOV3 cells.
    Jiang J; Wei D; Sun L; Wang Y; Wu X; Li Y; Fang Z; Shang H; Wei Z
    Oncol Rep; 2014 Feb; 31(2):781-7. PubMed ID: 24317390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Developing Implantable Scaffolds to Enhance Neural Stem Cell Therapy for Post-Operative Glioblastoma.
    Sheets KT; Ewend MG; Mohiti-Asli M; Tuin SA; Loboa EG; Aboody KS; Hingtgen SD
    Mol Ther; 2020 Apr; 28(4):1056-1067. PubMed ID: 32109370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytosine deaminase versus thymidine kinase: a comparison of the antitumor activity.
    Corban-Wilhelm H; Becker G; Bauder-Wüst U; Greulich D; Debus J
    Clin Exp Med; 2003 Nov; 3(3):150-6. PubMed ID: 14648229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Killing effect of double suicide genes mediated by lentivirus on lymphoma cells].
    Jiang YR; Ma DX; Chen XL; Liu CS
    Ai Zheng; 2003 Sep; 22(9):916-21. PubMed ID: 12969521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody-directed double suicide gene therapy targeting of MUC1- positive leukemia cells in vitro and in vivo.
    Dong XY; Wang WQ; Zhao Y; Li XD; Fang ZG; Lin DJ; Xiao RZ; Huang RW; Pan GJ; Liu JJ
    Curr Gene Ther; 2013 Oct; 13(5):346-57. PubMed ID: 24060312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrinsic properties of tumour cells have a key impact on the bystander effect mediated by genetically engineered mesenchymal stromal cells.
    Matuskova M; Baranovicova L; Kozovska Z; Durinikova E; Pastorakova A; Hunakova L; Waczulikova I; Nencka R; Kucerova L
    J Gene Med; 2012 Dec; 14(12):776-87. PubMed ID: 23150190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor effects of cytosine deaminase and thymidine kinase fusion suicide gene under the control of mdr1 promoter in mdr1 positive leukemia cells.
    Wang X; Ji C; Ma D; Zhao J; Hou M; Yu H; Zang S
    Leuk Lymphoma; 2007 Aug; 48(8):1600-9. PubMed ID: 17701592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thymidine kinase/ganciclovir and cytosine deaminase/5-fluorocytosine suicide gene therapy-induced cell apoptosis in breast cancer cells.
    Kong H; Tao L; Qi K; Wang Y; Li Q; Du J; Huang Z
    Oncol Rep; 2013 Sep; 30(3):1209-14. PubMed ID: 23799574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanoscale bubble ultrasound contrast agents-mediated suicide gene therapy system, Nanoscale bubble-LV5-YCD-TK/GCV/5-FC, effectively inhibits bladder cancer cell growth.
    Fu YR; Chen F; Luo Y; Yi YF
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):75-86. PubMed ID: 30657549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor activity of combined endostatin and thymidine kinase gene therapy in C6 glioma models.
    Chen Y; Huang H; Yao C; Su F; Guan W; Yan S; Ni Z
    Cancer Med; 2016 Sep; 5(9):2477-86. PubMed ID: 27366865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene Therapy Using Neural Stem/Progenitor Cells Derived from Human Induced Pluripotent Stem Cells: Visualization of Migration and Bystander Killing Effect.
    Tamura R; Miyoshi H; Morimoto Y; Oishi Y; Sampetrean O; Iwasawa C; Mine Y; Saya H; Yoshida K; Okano H; Toda M
    Hum Gene Ther; 2020 Mar; 31(5-6):352-366. PubMed ID: 32075424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Killing effect of human pulmonary adenocarcinoma cells with TK + CD/5-Fc + GCV coexpression suicide gene systems].
    Cao HQ; Zhao Y; Meng XM; Ding JF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Apr; 23(2):168-72. PubMed ID: 12905896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double suicide genes selectively kill human umbilical vein endothelial cells.
    Jia W; Mei L; Wang Y; Liu L; Che G
    Virol J; 2011 Feb; 8():74. PubMed ID: 21333030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Encapsulation of packaging cell line results in successful retroviral-mediated transfer of a suicide gene in vivo in an experimental model of glioblastoma.
    Martinet O; Schreyer N; Reis ED; Joseph JM
    Eur J Surg Oncol; 2003 May; 29(4):351-7. PubMed ID: 12711288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.